Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2866032-A1 European Patent Office 29 Apr 2015
Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2848939-A1 European Patent Office 18 Mar 2015
Method to identify a patient with an increased likelihood of responding to an anti-cancer… Application EP-2848940-A1 European Patent Office 18 Mar 2015
Plasma biomarker for bevacizumab combination therapy for breast cancer treatment Application JP-2015502543-A Japan 22 Jan 2015